Level Biotechnology Inc. (3118.TWO)
TWD 31.0
(-1.12%)
TWD 31.0
(-1.12%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 98.7 Million TWD | 6.39% |
| 2022 | 93 Million TWD | -11.59% |
| 2021 | 105.06 Million TWD | 11.95% |
| 2020 | 93.96 Million TWD | 17.21% |
| 2019 | 80.16 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 29.26 Million TWD | -3.69% |
| 2024 Q2 | 19.41 Million TWD | -33.66% |
| 2023 Q4 | 30.38 Million TWD | 57.8% |
| 2023 FY | - TWD | 6.39% |
| 2023 Q3 | 19.25 Million TWD | -18.7% |
| 2023 Q2 | 23.68 Million TWD | -6.64% |
| 2023 Q1 | 25.37 Million TWD | -4.15% |
| 2022 Q4 | 26.47 Million TWD | 0.0% |
| 2022 FY | - TWD | -11.59% |
| 2021 FY | - TWD | 11.95% |
| 2020 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 74.923% |
| Sagittarius Life Science Corp | -44.73 Million TWD | 320.622% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 236.87% |
| TaiMed Biologics Inc. | -25.23 Million TWD | 491.17% |
| GlycoNex Incorporation | -126.82 Million TWD | 177.826% |
| VBI | -6.97 Million TWD | 1515.72% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 168.69% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | -352.563% |
| Visgeneer Inc. | 973 Thousand TWD | -10044.296% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 129.075% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 89.46% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 1.135% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 109.959% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | 5782.441% |
| Enimmune corporation | -228.96 Million TWD | 143.109% |
| TaiRx, Inc. | -208.64 Million TWD | 147.307% |
| CHO Pharma, Inc. | -277.73 Million TWD | 135.539% |
| EirGenix Inc. | -664.4 Million TWD | 114.856% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | -33.557% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | -42.753% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 109.213% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 187.267% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | -183.323% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 258.329% |
| Lukas Biomedical Inc. | -26.3 Million TWD | 475.3% |
| RBC Bioscience Corporation | 36.54 Million TWD | -170.074% |
| BiOptic Inc. | 65.03 Million TWD | -51.764% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 114.463% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 399.049% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 279.74% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 77.234% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 313.442% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 656.832% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 195.26% |
| Neith Corporation | -33.61 Million TWD | 393.675% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 223.269% |
| NaviFUS Corp. | -55.79 Million TWD | 276.905% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 694.674% |
| Sinew Pharma Inc. | -163.63 Million TWD | 160.321% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 260.494% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 48.699% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 143.544% |
| AP Biosciences Inc | -325.51 Million TWD | 130.323% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 109.449% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 375.356% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | -238.84% |
| Intech Biopharm Corporation | -219.58 Million TWD | 144.95% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 114.64% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 319.581% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 161.361% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 84.943% |
| TCI GENE Inc. | 25.98 Million TWD | -279.908% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 189.213% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 134.781% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 167.619% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | -612.664% |
| PharmaEngine, Inc. | 347.3 Million TWD | 71.58% |
| Savior Lifetec Corporation | 219.6 Million TWD | 55.054% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 42.691% |
| OBI Pharma, Inc. | -855.08 Million TWD | 111.543% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 206.634% |
| Acepodia, Inc. | -764.51 Million TWD | 112.911% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 121.453% |